Using multigene panel testing, we found several novel germline mutations that have been rarely reported in hereditary colorectal cancer (e.g., ERCC4, SDHA, and XRCC2), but our limited sample size hindered us from determining their penetrance and relationship with colorectal cancer. Here, XRCC2 is linked to colorectal cancer.